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Abstract
Objectives: Forced‐diuresis during cardiopulmonary bypass (CPB) can be associated
with significant electrolyte shifts. This study reports on the serum electrolyte
changes during balanced forced‐diuresis with the RenalGuard® system (RG) dur-
ing CPB.
Methods: Patients at risk of acute kidney injury (AKI)—(history of diabetes &/or
anaemia, e‐GFR 20–60ml/min/1.73m2, anticipated CPB time >120min, Log Euro-
Score >5)—were randomized to either RG (study group) or managed as per current
practice (control group).
Results: The use of RG reduced AKI rate (10% for RG and 20.9% in control, p = .03).
Mean urine output was significantly higher in the RG group during surgery
(2366 ± 877ml vs. 765 ± 549 ml, p < .001). The serum potassium levels were main-
tained between 3.96 and 4.97mmol/L for the RG group and 4.02 and 5.23mmol/L
for the controls. Median potassium supplemental dose was 60 (0–220) mmol (RG
group) as compared to 30 (0–190) mmol for control group over first 24 h (p < .001).
On Day 1 post‐op, there were no significant differences in the serum sodium, po-
tassium, calcium, magnesium, phosphate, and chloride levels between the two
groups. Otherwise, postoperative clinical recovery was also similar.
Conclusions: Balanced forced‐diuresis with the RG reduced AKI rates after on‐pump
cardiac surgery compared to controls. Although the RG group required higher doses
of IV potassium replacement in the postoperative period, normal serum levels of
potassium were maintained by appropriate intravenous potassium supplementation
and the clinical outcomes between groups were similar.
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1 | INTRODUCTION
The development of acute kidney injury (AKI) after cardiac surgery
has been reported to be associated with significant postoperative
morbidity and mortality both in the short‐term and the long‐term.1,2
Many strategies have been described to reduce AKI3 and the use of
the RenalGuard® system (RG) (RenalGuard Solutions Inc.) has re-
cently been reported to reduce AKI rates after cardiac surgery.4
The principles and components of RG have been extensively de-
scribed in previous reports.4,5 In brief, it is a closed‐loop fluid manage-
ment system which allows forced‐diuresis to be induced with low dose
(0.25–0.5mg/Kg) furosemide while inadvertent volume depletion is
prevented by the administration of intravenous (i.v) fluids at a rate which
can be matched in real‐time to the urine output. Its components include a
high‐volume fluid pump, a high‐accuracy dual weight measuring system, a
single‐use i.v set and a urine collection system that interfaces with
standard Foley urinary catheter. There are, also, (a) real‐time displays of
fluid replacement and urine volumes, (b) safety features such as automatic
air and occlusion detection and (c) alerts to drain the urine bag or to
replace hydration fluid bag. The RG console measures the volume of urine
in the collecting set, then calculates urine flow rate and finally, infuses a
pre‐set volume of hydration fluid to match the urine output, as decided
by the treating physician. The console allows the user to set either an
overall equal fluid balance (zero balance) or a net fluid gain above or loss
below matched hydration as well as allowing the user to infuse fluid
boluses.
It is well recognised that diuresis, especially by loop diuretics, is as-
sociated with electrolyte losses. The loop diuretics block the NKCC2
(sodium potassium chloride co‐transporter) channels present on the apical
membrane of the thick ascending limb of the loop of Henle causing
sodium and potassium excretion in the urine.6 Other effects of loop
diuretics include metabolic alkalosis, hypocalcaemia, hypomagnesemia
and hypochloraemia. Moreover, the use of the cardiopulmonary bypass
machine (CPB) during cardiac surgery also causes significant volume and
electrolytes shifts.7 These changes can lead to arrhythmias, cardiac dys-
function, brain oedema and in severe cases, neuronal demyelination.8
These effects are modulated due to alterations in cellular metabolism, cell
membrane potentials and energy transformations. It is therefore im-
perative that the electrolytes levels are monitored during cardiac surgery
and replenished appropriately and in a timely fashion.
This randomised control trial assessed the electrolyte changes (sec-
ondary outcomes) between patients treated with balanced forced‐
diuresis (RG group) compared to controls, during cardiac surgery and
within the first 24‐h post‐op, along with the clinical impact during the in‐
hospital stay.
2 | MATERIALS AND METHODS
2.1 | Ethical approval
The KIDNEY study (Kidney protection using the RenalGuard® sys-
tem in cardiac surgery) was reviewed and approved by the
Institutional Research Committee (16CARD13) before seeking Ethical
committee (16/NI/0246, 2nd December 2016) approval and was
registered on ClinicalTrials.gov website (NCT02974946). The study
was also supported by the National Institute of Healthcare Research,
Clinical Research Network, United Kingdom (NIHR ID: 32769). All
recruited patients gave written informed consent to partake in the
study. Trial patients were treated according to the Declaration of
Helsinki 2013.
2.2 | Aims and objectives
The primary aim of the study assessed the impact of the RG system
on the reduction of AKI (RIFLE—Risk, Injury, Failure, Loss of kidney
function, End‐stage renal disease—criteria definition—50% increase in
pre‐op “baseline” serum creatinine within first 3 days of surgery) in
patients undergoing cardiac surgery. Baseline creatinine was defined
as latest creatinine level available before surgery. Secondary aims
included the electrolyte changes during surgery and within 24‐h post‐
op as well as their impact on clinical outcomes during hospital stay.
The primary outcome has already been published4 and the secondary
objectives are being reported in this study.
2.3 | Inclusion criteria
The inclusion criteria for recruited patients were one or more of the
following: (i) diabetics (insulin or noninsulin dependent diabetes
mellitus), (ii) eGFR of 20–60ml/min/1.73m2, (iii) Logistic Euroscore
of 5 or above, (iv) haemoglobin level of 12.5 g/dl or below and (v)
cardiac procedures when CPB time was likely to exceed 120min.
2.4 | Interventions
A research‐independent person based in the Research & Develop-
ment department devised and managed a sealed opaque envelope
system for randomisation of consented patients. In patients rando-
mised to the RG system, balanced forced diuresis was started in
anaesthetic room after patient intubation and continued throughout
the cardiac procedure in the operating room (OR) and for up to 6 h
after cardiac intensive care unit (CICU) admission. Forced‐diuresis
was initiated with 20mg bolus of IV furosemide. In some patients, the
urine output rate was maintained by a furosemide infusion which was
titrated to 10mg/hour during surgery, with the aim of achieving a
urine output of at least 200ml/hour. This infusion was stopped in the
OR at the end of procedure. In this study, patients were managed at a
zero balance i.e. volume of urine output was matched in real‐time to
the volume of Hartmann's fluid replacement infusion given through
the RG system. On CICU, the RG system was continued for 6 h
(matching Hartmann's i.v infusion rate to urine output rate). Addi-
tional furosemide bolus (20 mg i.v) was administered whenever the
urine output fell below the 200ml/hour threshold within the first 6‐h
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postadmission to CICU. Control group patients were managed as per
current medical practice. They did not receive i.v furosemide in the
OR. Otherwise, the management of the patients was similar including
the anaesthetic technique and cardiopulmonary bypass run including
the need for inotropic support to maintain a mean arterial pressure
(MAP) >65mmHg. CPB‐flow was calculated and maintained at a
cardiac index of 2.4 l/min/m2. Bypass was performed at mild to
moderate (32–34°C) hypothermia and patients were warmed to na-
sopharyngeal temperature of 36.5–37°C and bladder temperature
of >35°C before discontinuation of CPB. The cardioplegia soution
(Harefield Hospital formulation) had the following constituents:
sodium—147mmol/l, potassium—84mmol/l, calcium—2mmol/l,
magnesium—80mmol/l, procaine—5mmol/l and chloride 400mmol/
l. This was mixed with cold blood in a ratio 1:4 for myocardial pro-
tection during surgery.
2.5 | Statistical analysis
To achieve the primary end‐point with a power of 0.8 and an alpha of
0.05, 110 patients per group were deemed adequate as per the
power calculations. Categorical data are expressed as percentages
and differences between the two groups assessed using the chi
square (χ2) test of independence. Continuous variables are expressed
as median (minimum, maximum) or mean (SD) for skewed and
Gaussian distributed data, respectively. Group comparison was car-
ried out using two‐tailed t test or Mann–Whitney U test accordingly.
Repeated measures were analysed via the generalised linear model
for the changes in the variables (electrolytes, lactate, haemoglobin
levels) across the various time points between the two groups and
adjusted for any differences by the Bonferroni corrections. The tests
were considered significant at p < .05. SPSS version 26.0 (IBM SPSS
statistics 26) was used for statistical analyses.
Patients' recruitment was from 1st March 2017 to 4th Septem-
ber 2019. All patients' data were analysed on an intention to treat
basis.
3 | RESULTS
A total of 220 patients were randomised to the study (110 patients
per group). Pre and intraoperative patients' data were not sig-
nificantly different between the two groups (Table 1). The primary
outcome of postoperative AKI was significantly lower in the RG
group as compared to controls (10% vs. 20.9%, p = .025).
The secondary aims of mean volumes of urine produced during
surgery (2366 ± 877ml vs. 765 ± 549ml) and within first 24‐h post‐
op on CICU (3310 ± 1303ml vs. 2052 ± 804ml) were significantly
higher in RG group (p < .001).
The median volumes of cold blood cardioplegia used were 2070
(995, 5381) ml and 1933 (1000, 5339) ml, respectively (p = .8). Pa-
tients in RG group received a median dose of 28 (0, 92) mg i.v fur-
osemide in the OR. On the CICU 61% of study group (median dose
20 [0, 160] mg) and 53% of control group (median dose 20 [0, 180]
mg) received i.v furosemide within the first 24 h of CICU admission
(p = .99). There were no statistically significant differences between
the groups in terms of the MAP and CVP during surgery and on the
CICU. Similarly, there was no significant difference between (a)
the haemoglobin levels during and after surgery (Figure 1) and (b) the
postoperative blood transfusion rates (27% vs. 19%, p = .16), inclusive
of intraoperative transfusions.
Patients in the study group required significantly higher doses of
i.v potassium supplementation to maintain normal serum levels, with
median potassium supplemental dose being 60 (0–220) mmol for RG
as compared to 30 (0–190) mmol for control group over 24 h
(p < .001). The serum potassium levels were maintained between 3.96
and 4.97mmol/L for the RG group and 4.02 and 5.23mmol/L for the
controls. The changes in the strong ion difference ([Na+ + K+ +
Ca2+ +Mg2+ levels] minus [Cl− + lactate levels]) are shown in Figure 2.
The changes in serum electrolytes (sodium, potassium), lactate and
pH levels are depicted in Figure 3. On the first postoperative day,
there were no significant differences in the sodium, potassium, cal-
cium, magnesium, phosphate and chloride serum levels, between the
two groups (Table 1).
There was no significant difference in incidence of atrial fi-
brillation rate, infections (chest, surgical site infection, sepsis), post-
operative cerebro‐vascular events rate and median durations of CICU
stays between the two groups. The median in‐hospital stay was
6 days for both groups.
One patient in RG group and two patients in control group died
before hospital discharge. Causes of death were not related to the
use of device and included cardiogenic shock, cardiac failure and
sepsis (pneumonia) respectively.
4 | DISCUSSION
The primary aim of this study was confirmed4 as AKI rate was re-
duced when the RG system was used perioperatively in cardiac
surgery. The study also found that there were statistically significant
electrolyte shifts during the use of the CPB and when it is combined
with forced‐diuresis provided by the RG system. However, these
changes did not impact on clinical outcomes.
Polderman reported electrolytes depletion in patients under-
going surgery with the CPB machine. The author suggested that
these could be due to the intracellular shifts of electrolytes which are
induced by hypothermia as well as urinary excretion of these elec-
trolytes which was independent of the use of perioperative diure-
tics.9 The current study confirmed similar electrolytes shifts.
However, clinically there was no significant difference in the patients'
recovery as the levels of these electrolytes were closely monitored
and supplementation of any electrolyte depletion was carried out in a
timely manner.
Another important aspect which could influence electrolytes
shifts is the acid–base status of the patient in particular, alkalosis.7
The latter is also assessed regularly during cardiac surgery and in the
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postoperative phase. There was no significant difference between
the two groups in terms of bicarbonate and pH levels. Correction of
acid–base disturbances can be through respiratory, renal or phar-
macological routes.
The use of CPB circuit is recognized to lead to metabolic acidosis
possible as a consequence of bicarbonate dilution.10 As per the
Stewart calculations,11 metabolic acid–base status is a function of
two independent variables interacting in intravascular and interstitial
compartments: the strong ion difference and the concentration of
nonvolatile weak acid. The former is the net charge of all fully dis-
sociated ions (sum of Na+, K+ , Ca2+ , Mg2+ levels minus the sum of
Cl− and lactate levels). As for the weak‐acid, it consists of albumin and
phosphate in the extracellular fluid, whereas within erythrocytes, it is
primarily haemoglobin. An isolated increase in weak‐acid or a de-
crease in strong ion difference creates a metabolic acidosis. Changes
in opposite directions, respectively, cause a metabolic alkalosis. In
normal individuals not undergoing surgery a strong ion difference of
around 40–45mEq/L is considered normal12 whereas during a CPB
run, a crystalloid strong ion difference of 24mEq/L produces a ba-
lanced CPB with normal acid–base status.13 In this study the mean
strong ion difference between the RG group and control group was
similar at most time‐points except during the period of 6–12 h post
ICU admission (Figure 2). Nevertheless, it was maintained between
30 and 45mEq/L throughout the perioperative period.
The CPB circuit also causes significant haemodilution, hypo-
magnesaemia, and hyponatraemia. Haemodilution, as also discussed,
causes acid–base changes. The degree of haemodilution can be
minimized by using the retrograde autologous priming technique
(RAP) where the priming volume is kept to around 1 L.14 This ap-
proach was used during this study and despite large volume diuresis
and volume replacement in the RG group, the transfusion rate was
similar between both groups as were the haemoglobin levels around
the perioperative period. Precipitous hyponatraemia on CPB initia-
tion can lead to osmotic demyelination syndrome causing cerebral
injury and paralysis.8 Moreover, forced diuresis can exacerbate the
degree of sodium ion loss. Thus it is important that the electrolytes
are monitored appropriately. Last but not least, low magnesium levels
have been reported during and after CPB.15 This can translate into
clinical episodes of cardiac arrhythmias. In this study, both groups
had similar and normal levels of magnesium.
TABLE 1 Peri‐op characteristics of
patients in the two groups
RG group (n = 110) Control group (n = 110) p value
Agea, years 67.8 (9.3) 67.0 (9.2) .33
Male (n, %) 87, 79% 84, 76% .63
Nondiabetics (n, %) 30, 27% 30, 27% .66
Pre‐op CVA (n, %) 11,10% 8, 7% .63
Urgent surgery (n, %) 34, 31% 24, 22% .13
STS mortality scoreb 0.96 (0.24, 6.63) 0.88 (0.20, 6.95) .15
Pre‐op creatininea, micromol/L 99.0 (28.2) 98.3 (34.7) .29
Pre‐op haemoglobina, g/L 135 (16) 134 (18) .72
Operative procedures .38
Isolated CABG (n, %) 53, 48% 59, 54%
Isolated valve (n, %) 15, 15% 19, 18%
Combined procedures (n, %) 40, 37% 31, 28%
Day‐1 sodium levela, mmol/L 139 (3) 139 (2) .35
Day‐1 potassium levela, mmol/L 4.7 (0.2) 4.7 (0.3) .79
Day‐1 calcium levela, mmol/L 1.2 (0.3) 1.3 (0.4) .06
Day‐1 magnesium levela, mmol/L 1.1 (0.2) 1.1 (0.2) .41
Day‐1 phosphate levela, mmol/L 1.1 (0.2) 1.1 (0.2) .21
Day‐1 bicarbonate levela, mmol/L 24 (2) 24 (2) .92
Day‐1 chloride levela, mmol/L 105 (2) 105 (3) .79
Day‐1 Haemoglobina, g/L 99 (15) 102 (16) .29
Abbreviations: CABG, coronary artery bypass surgery; CICU, cardiac intensive care unit; CVA,
cerebro‐vascular accident; e‐GFR, estimated glomerular filtration rate; STS, Society of Thoracic Surgery.
aDenotes mean (SD).
bDenotes median (minimum, maximum).
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F IGURE 1 Haemoglobin levels in the perioperative period. Pre‐op: in anaesthetic room, Pre‐CBP: before initiation of cardiopulmonary
bypass. On‐CPB1: on cardiopulmonary bypass for 15min, On‐CPB2: before stopping cardiopulmonary bypass, Post‐CPB: poststopping
cardiopulmonary bypass for 15min. ICU1: on arrival to ICU, ICU2: on ICU for 6 h, ICU3: On ICU for 12 h, ICU4: On ICU for 24 h. ICU, intensive
care unit
F IGURE 2 The strong ion difference levels (not significantly different except at ICU2* and ICU3* periods) at various time periods—Pre‐op: In
anaesthetic room, Pre‐CBP: before initiation of cardiopulmonary bypass. On‐CPB1: on cardiopulmonary bypass for 15min. On‐CPB2: before
stopping cardiopulmonary bypass, post‐CPB: poststopping cardiopulmonary bypass for 15min. ICU‐0 h: on arrival to ICU, ICU‐6 h: on ICU for
6 h, ICU‐12 h: on ICU for 12 h, ICU‐24 h: on ICU for 24 h. ICU, intensive care unit
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4.1 | Limitations
This was a single centre study. Moreover, as the study was not
blinded, the management of the control group could have been in-
fluenced by some aspects of the Hawthorne effect.
5 | CONCLUSION
In patients at‐risk for AKI, undergoing cardiac surgery with CPB,
balanced forced‐diuresis as provided by the RG system significantly
reduced the incidence of AKI. Compared to the control group, serum
potassium levels were lower in the RG group. However, normal levels
could be maintained by administration of IV potassium replacement
in the postoperative period, thus maintaining similar clinical out-
comes, with no adverse safety concerns.
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